Clonotypic IgM transcripts are detectable among purified sIgM plus B cells from the peripheral blood of patients with multiple myeloma.

被引:0
|
作者
Ye, M [1 ]
Taylor, BJ [1 ]
Keats, JK [1 ]
Belch, AR [1 ]
Pilarski, LM [1 ]
机构
[1] Univ Alberta, Edmonton, AB T6G 2M7, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5214
引用
收藏
页码:371B / 372B
页数:2
相关论文
共 50 条
  • [41] Frequency and kinetics of polyclonal and clonal B cells in the peripheral blood of patients being treated for multiple myeloma
    Rasmussen, T
    Jensen, L
    Honoré, L
    Johnson, HE
    BLOOD, 2000, 96 (13) : 4357 - 4359
  • [42] Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma.
    Eveillard, Marion
    Rustad, Even
    Roshal, Mikhail
    Zhang, Yanming
    Ciardiello, Amanda
    Korde, Neha
    Hultcrantz, Malin
    Hassoun, Hani
    Smith, Eric L.
    Lesokhin, Alexander M.
    Mailankody, Sham
    Landgren, Carl Ola
    Thoren, Katie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Antigen profiles of peripheral blood stem cells from healthy donors and multiple myeloma patients
    Krol, MA
    Czuba, E
    Feliksbrot, M
    Krol, MI
    Graczyk-Pol, E
    Rokicka, M
    Torosian, T
    Urbanowska, E
    Jedrzejczak, WW
    Dwilewicz-Trojaczek, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S257 - S257
  • [44] Next-generation sequencing of peripheral B-lineage cells pinpoints the circulating clonotypic cell pool in multiple myeloma
    Thiele, Benjamin
    Kloster, Marie
    Alawi, Malik
    Indenbirken, Daniela
    Trepel, Martin
    Grundhoff, Adam
    Binder, Mascha
    BLOOD, 2014, 123 (23) : 3618 - 3621
  • [45] Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.
    Liso, A
    Stockerl-Goldstein, KE
    Aufferman, S
    Benike, CJ
    Reichardt, V
    van Beckhoven, A
    Rajapaksa, R
    Engleman, EG
    Blume, KG
    Levy, R
    BLOOD, 1999, 94 (10) : 715A - 715A
  • [46] A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma.
    Siegel, D
    Vij, R
    Vescio, RA
    Borrello, IM
    Martin, TG
    Berenson, JR
    Ferrand, C
    Janmohamed, F
    Berenson, RJ
    Frohlich, MW
    BLOOD, 2004, 104 (11) : 265A - 265A
  • [47] Ifosfamide/epirubicine and granulocyte colony-stimulating factor is resulting in successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma.
    Arland, M
    Lange, S
    Franke, A
    Kahl, C
    Hoeffkes, HG
    BLOOD, 2000, 96 (11) : 313B - 313B
  • [48] A phase I/II study of Xcellerated T cells after autologous peripheral blood stem cell transplantation in patients with multiple myeloma.
    Borrello, IM
    Vij, R
    Vescio, RA
    Martin, TG
    Siegel, D
    Berenson, JR
    Janmohamed, F
    Bonyhadi, M
    Berenson, RJ
    Frohlich, MW
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 173S - 173S
  • [49] A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma.
    Vij, R
    Borrello, IM
    Martin, T
    Vescio, R
    Siegel, D
    Bashey, A
    DiPersio, JF
    Berenson, J
    Ferrand, C
    Janmohamed, F
    Yuan, V
    Bouchard, L
    Berenson, RJ
    Bonyhadi, M
    Frohlich, MW
    BLOOD, 2003, 102 (11) : 43A - 43A
  • [50] SEMI-AMBULATORY AUTOLOGOUS PERIPHERAL BLOOD STEM-CELL TRANSPLANTATION IN 79 PATIENTS WITH MULTIPLE MYELOMA.
    Gac, A. C.
    Chantepie, S.
    Marin, E.
    Cabrera, Q.
    Cheze, S.
    Johnson, H.
    Benabed, K.
    Batho, A.
    Macro, M.
    Reman, O.
    HAEMATOLOGICA, 2012, 97 : 715 - 716